Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

R&D Market Pulse: Tariffs Could Lower Automotive R&D Investments

By R&D Editors | June 25, 2018

The DJIA part of the stock market was down more than 600 points last Monday through Thursday and up about 119 points on Friday to end the week about 500 points down. Alternatively, the R&D Index was down just 28 points by Thursday and ended the week just 40 points down. The DJIA’s wild ride was due primarily to the increased trade war pronouncements by Trump and European and Asian leaders. The five automotive members of the R&D Index were all down significantly (average of -5.06%), which took the brunt of the DJIA and R&D Index market declines due to their focus in the trade discussions. Germany-based Daimler was particularly hard hit (-7.33%) with their corporate leaders stating that 2018 profits were going to be severely affected by the ongoing tariff events. These will likely have a moderating effect on monies available for R&D investments, as well. The five automotive R&D Index members all have global production facilities that would be affected by the global tariffs on both sides, which is likely to increase their costs and depress sales. They also have a combined 2018 R&D of about $39.6 billion which could see a decline in 2019 to offset their economic issues.

The Trump administration has proposed a sweeping reorganization of several government agencies including the creation of a new Dept. of Health and Public Welfare, which would replace the Dept. of Health and Human Services. HHS includes the R&D-heavy National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). These changes would require Congressional approval which is unlikely to occur until after the November elections, but it makes a statement for Trump’s goal of shrinking the overall government. The proposal also would combine the Dept. of Labor with the Dept. of Education to support job training concerns.

GE, one of the original 12 DJIA members, was dropped and replaced by Walgreens Boots Alliance ending GE’s 111-year history on the index. GE stock has dropped 55% over the past year. It was expected to spend $3.7 billion on R&D in 2018, down from $4.2 billion in 2017. It has been divesting itself from many of its divisions over the past several years, including its locomotive business, and would be expected to slowly lower its R&D presence.

      R&D Index Week Ending June 22, 2018      
  Ticker Exchange 2017 R&D billions$ 06/15/18 06/22/18 6/22/18 to 6/15/18 6/22/18 to 12/29/17
Amazon AMZN NASDAQ 17,774 1,715.97 1,715.67 -0.02% 46.70%
Alphabet/Google GOOGL NASDAQ 15,845 1,159.27 1,155.48 -0.33% 9.69%
Microsoft MSFT NASDAQ 13,987 100.13 100.41 0.28% 17.38%
Intel INTC NASDAQ 13,499 55.11 52.50 -4.74% 13.73%
Apple AAPL NASDAQ 11,506 188.84 184.92 -2.08% 9.27%
Volkswagen AG VLKAY OTC 11,260 36.74 34.58 -5.88% -14.49%
Roche Pharm RHHBY OTC 10,174 26.64 27.77 4.24% -12.06%
Toyota TM NYSE 9,170 135.81 131.00 -3.54% 3.01%
Johnson & Johnson JNJ NYSE 9,060 122.61 122.84 0.19% -12.08%
Novartis NVS NYSE 7,870 75.79 75.06 -0.96% -10.60%
General Motors GM NYSE 7,468 43.91 41.25 -6.06% 0.63%
Pfizer PFE NYSE 7,288 36.36 36.51 0.41% 0.80%
Bristol-Myers Squibb BMY NYSE 6,942 54.80 55.14 0.62% -10.02%
Cisco CSCO NASDAQ 6,827 44.25 43.20 -2.37% 12.79%
Qualcomm QCOM NASDAQ 6,723 59.86 58.50 -2.27% -8.62%
Oracle ORCL NYSE 6,702 46.28 44.10 -4.71% -6.73%
Honda HMC NYSE 6,519 31.82 30.54 -4.02% -10.39%
Astra Zeneca PLC AZN NYSE 6,363 36.41 35.06 -3.71% 1.04%
Merck & Co. MRK NYSE 5,759 62.03 61.47 -0.90% 9.24%
Daimler DDAIY OTC 5,084 72.57 67.25 -7.33% -20.47%
Bayer AG BAYN OTC 4,880 31.53 29.02 -7.96% -6.66%
Sanofi SA SNY NYSE 4,755 39.94 40.00 0.15% -6.98%
IBM IBM NYSE 4,628 145.39 141.28 -2.83% -7.91%
GlaxoSmithKline GSK NYSE 4,508 41.44 40.89 -1.33% 15.28%
Eli Lilly Co LLY NYSE 4,489 86.88 85.92 -1.10% 1.73%
Total     209,080 4,450.38 4,410.36 -0.90% 16.31%
               
    Biopharmaceutical 614.43 609.68 -0.77% -4.40%
    Automotive 320.85 304.62 -5.06% -6.91%
    ICT   1,799.13 1,780.39 -1.04% 7.42%

About the R&D Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2017 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2017 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Amazon, Alphabet/Google, Microsoft, Intel, Apple, Volkswagen AG, Roche Pharma, Toyota, Johnson & Johnson, Novartis, General Motors, Pfizer, Bristol-Myers Squibb, Cisco, Qualcomm, Oracle, Honda Motor Company, Astra Zeneca plc, Merck & Company, Daimler, Bayer AG, Sanofi SA, IBM, GlaxoSmithKline and Eli Lilly Co. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.5 and $17 billion annually on their R&D efforts.

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
7 major R&D developments this week: Tariff uncertainty persists, Pfizer sells campus, Scania acquires Northvolt unit
economic crisis stock chart falling down business global money bankruptcy concept
7 major R&D developments this week: Tariffs roil markets, MIT wins $12B contract, Siemens plans $5B acquisition
EL SEGUNDO, CA/USA - OCTOBER 13, 2014: Boeing manufactuing facility. Boeing manufactures and sells aircraft, rotorcraft, rockets and satellites. It is the second-largest defense contractor in the world.
8 major R&D moves this week: HHS cuts 10,000 jobs while Anthropic & DataBricks form $100M pact
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE